WS #12014

22:32→23:02 UTC

From 500 msgs · 7 key-dev

FDA approves subcutaneous version of Biogen's Alzheimer's drug Leqembi for initiation and maintenance dosing, including at-home use.

Biogen Leqembi Approval

FDA approves subcutaneous version of Biogen's Alzheimer's drug Leqembi for initiation and maintenance dosing, including at-home use.